(603590)"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Change of Registered Capital and Amendment to the Articles of Association
Filed with SSE · Stock code 603590 · · 2 pages · Chinese
Summary by 6ix AI
Beijing Konruns Pharmaceutical Co., Ltd. announced changes to its registered capital and amendments to its Articles of Association. The company plans to repurchase and cancel a portion of restricted stock, resulting in a decrease in total shares and registered capital. The amendments to the Articles of Association reflect these changes in registered capital and total shares. These matters will be submitted for approval at the upcoming shareholders' meeting.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Beijing Konruns Pharmaceutical Co., Ltd. on 6ix
Story so far
Earlier from Beijing Konruns Pharmaceutical
- (603590)"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Progress in Repurchasing Shares
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on the Arbitration Result
- Announcement on Results of the Initial Grant under the 2026 Restricted Share Incentive Plan
- Announcement on Obtaining New Veterinary Drug Registration Certificate
Later from Beijing Konruns Pharmaceutical
- (603590)"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Implementation Results of Share Repurchase and Share Changes
- (603590)"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Receipt of Clinical Trial Approval Notice for KC1086 Combined with Fulvestrant for the Treatment of HR+HER2- Locally Advanced or Metastatic Breast Cancer
Follow Beijing Konruns Pharmaceutical into a list and get an email when it puts out news.
Follow Beijing Konruns Pharmaceutical